{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:32:16Z","timestamp":1792081936410,"version":"4.4.0"},"reference-count":178,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.jad.2005.05.003","type":"journal-article","created":{"date-parts":[[2005,7,13]],"date-time":"2005-07-13T22:12:55Z","timestamp":1121292775000},"page":"27-45","source":"Crossref","is-referenced-by-count":255,"title":["A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia"],"prefix":"10.1016","volume":"88","author":[{"given":"Kristin","family":"Mitte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2005.05.003_bib1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000030642","article-title":"Zum Stellenwert psychotherapeutisch-pharmakologischer Kombinationstherapien bei Angstst\u00f6rungen","volume":"8","author":"Angenendt","year":"1998","journal-title":"Verhaltenstherapie"},{"key":"10.1016\/j.jad.2005.05.003_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0165-0327(98)00147-5","article-title":"Double-blindness procedure did not mask giving of medication in panic disorder","volume":"54","author":"Bakker","year":"1999","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2005.05.003_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1034\/j.1600-0447.2002.02255.x","article-title":"SSRIs vs. TCas in the treatment of panic disorder: a meta-analysis","volume":"106","author":"Bakker","year":"2002","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.jad.2005.05.003_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1037\/0033-295X.84.2.191","article-title":"Self-efficacy: toward a unifying theory of behavioral change","volume":"84","author":"Bandura","year":"1977","journal-title":"Psychological Review"},{"key":"10.1016\/j.jad.2005.05.003_bib18","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1001\/archpsyc.1997.01830200078011","article-title":"Double-blindness procedures, rater blindness, and ratings of outcome. Observations from a controlled trial","volume":"54","author":"Basoglu","year":"1997","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0005-7967(96)00069-1","article-title":"An information processing model of anxiety: automatic and strategic processes","volume":"35","author":"Beck","year":"1996","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.jad.2005.05.003_bib24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.2044-8317.1988.tb00901.x","article-title":"Synthesizing standardized mean-change measures","volume":"41","author":"Becker","year":"1988","journal-title":"British Journal of Mathematical & Statistical Psychology"},{"key":"10.1016\/j.jad.2005.05.003_bib25","series-title":"The Handbook of Research Synthesis","first-page":"399","article-title":"Publication Bias","author":"Begg","year":"1994"},{"key":"10.1016\/j.jad.2005.05.003_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0165-0327(94)90131-7","article-title":"Predictors of short-term response in 66 patients with panic disorder","volume":"30","author":"Black","year":"1994","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2005.05.003_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00004850-199503000-00006","article-title":"Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis","volume":"10","author":"Boyer","year":"1995","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2005.05.003_bib33","series-title":"Anxiety and Its Disorders: The Nature and Treatment of Anxiety and Panic","first-page":"292","article-title":"Classification of anxiety and mood disorder","author":"Brown","year":"2002"},{"key":"10.1016\/j.jad.2005.05.003_bib37","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1037\/0022-006X.61.2.248","article-title":"Cognitive therapy of anxiety disorders","volume":"61","author":"Chambless","year":"1993","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1016\/j.jad.2005.05.003_bib39","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0005-7967(86)90011-2","article-title":"A cognitive approach to panic","volume":"24","author":"Clark","year":"1986","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.jad.2005.05.003_bib43","series-title":"Coping with Panic","author":"Clum","year":"1990"},{"key":"10.1016\/j.jad.2005.05.003_bib44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1037\/0022-006X.61.2.317","article-title":"A meta-analysis of treatments for panic disorder","volume":"61","author":"Clum","year":"1993","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1016\/j.jad.2005.05.003_bib46","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0006-3223(98)00300-X","article-title":"Brain circuits in panic disorder","volume":"44","author":"Coplan","year":"1998","journal-title":"Biological Psychiatry"},{"issue":"Suppl. A","key":"10.1016\/j.jad.2005.05.003_bib48","first-page":"A87","article-title":"An integrated treatment approach to panic disorder","volume":"60","author":"Craske","year":"1996","journal-title":"Bulletin of the Menninger Clinic"},{"key":"10.1016\/j.jad.2005.05.003_bib51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0146-6402(92)90010-L","article-title":"Classical conditioning and the acquisition of human fears and phobias: a review and synthesis of the literature","volume":"14","author":"Davey","year":"1992","journal-title":"Advances in Behaviour Research and Therapy"},{"key":"10.1016\/j.jad.2005.05.003_bib57","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel plot based method of testing and adjusting for publication bias in meta-analysis","volume":"50","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.jad.2005.05.003_bib68","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1192\/bjp.112.484.309","article-title":"Severe agoraphobia: a controlled prospective trial of behavior therapy","volume":"112","author":"Gelder","year":"1966","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_bib71","series-title":"The Handbook of Research Synthesis","first-page":"340","article-title":"Stochastically dependent effect sizes","author":"Gleser","year":"1994"},{"issue":"Suppl. 2","key":"10.1016\/j.jad.2005.05.003_bib72","first-page":"4","article-title":"Toward an integrated neurobiology of panic disorder","volume":"58","author":"Goddard","year":"1997","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_bib73","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1176\/appi.ajp.157.4.493","article-title":"Neuroanatomical hypothesis of panic disorder, revised","volume":"157","author":"Gorman","year":"2000","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_bib76","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0272-7358(95)00048-8","article-title":"A meta-analysis of treatment outcome for panic disorder","volume":"15","author":"Gould","year":"1995","journal-title":"Clinical Psychology Review"},{"key":"10.1016\/j.jad.2005.05.003_bib78","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1037\/1082-989X.3.3.339","article-title":"Using odds ratio as effect sizes for meta-analysis of dichotomous data: a primer on methods and issues","volume":"3","author":"Haddock","year":"1998","journal-title":"Psychological Methods"},{"key":"10.1016\/j.jad.2005.05.003_bib79","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/09540260220144966","article-title":"Quality of life in depression and anxiety","volume":"14","author":"Hansson","year":"2002","journal-title":"International Review of Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_bib81","series-title":"Statistical Methods for Meta-Analysis","author":"Hedges","year":"1985"},{"key":"10.1016\/j.jad.2005.05.003_bib82","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1037\/1082-989X.3.4.486","article-title":"Fixed- and random-effects models in meta-analysis","volume":"3","author":"Hedges","year":"1998","journal-title":"Psychological Methods"},{"key":"10.1016\/j.jad.2005.05.003_bib183","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1097\/00004714-199312001-00001","article-title":"Clinical uses of benzodiazepines","volume":"13","author":"Hollister","year":"1993","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2005.05.003_bib85","series-title":"Methods of Meta-Analysis","author":"Hunter","year":"1990"},{"issue":"Suppl. 10","key":"10.1016\/j.jad.2005.05.003_bib87","first-page":"11","article-title":"Panic disorder: relationship to high medical utilization, unexplained physical symptoms, and medical costs","volume":"57","author":"Katon","year":"1996","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_bib89","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00005053-199405000-00007","article-title":"Remission and relapse in subjects with panic disorder and panic with agoraphobia: a prospective short interval naturalistic follow-up","volume":"182","author":"Keller","year":"1994","journal-title":"Journal of Nervous and Mental Disorders"},{"key":"10.1016\/j.jad.2005.05.003_bib90","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1192\/S0007125000298371","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey","volume":"168","author":"Kessler","year":"1994","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_bib91","doi-asserted-by":"crossref","unstructured":"Kirsch, I., Sapirstein, G., 1998. Listening to prozac but hearing placebo: a meta-analysis of antidepressant medication. Prevention and Treatment, 1, Artikel 0002a, http:\/\/journals.apa.org\/prevention\/volume1\/pre0010002a.html.","DOI":"10.1037\/\/1522-3736.1.0002a"},{"key":"10.1016\/j.jad.2005.05.003_bib94","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/jama.265.6.742","article-title":"Panic attacks in the community: social morbidity and health care utilization","volume":"265","author":"Klerman","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2005.05.003_bib99","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000073451","article-title":"Quality of life in anxiety disorders: a comparison of obsessive\u2013compulsive disorder, social anxiety disorder, and panic disorder","volume":"36","author":"Lochner","year":"2003","journal-title":"Psychopathology"},{"key":"10.1016\/j.jad.2005.05.003_bib106","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1037\/0022-006X.59.1.184","article-title":"How .blind. are double-blind studies?","volume":"59","author":"Margraf","year":"1991","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1016\/j.jad.2005.05.003_bib107","series-title":"Agoraphobia and Panic Disorder","author":"Marks","year":"1989"},{"key":"10.1016\/j.jad.2005.05.003_bib108","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1192\/bjp.176.6.507","article-title":"Fear reductions by psychotherapies. Recent findings, future directions","volume":"176","author":"Marks","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-7358(96)00042-6","article-title":"What meta-analyses have and have not taught us about psychotherapy effects: a review and future directions","volume":"17","author":"Matt","year":"1997","journal-title":"Clinical Psychology Review"},{"key":"10.1016\/j.jad.2005.05.003_bib114","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1176\/appi.ajp.157.5.669","article-title":"Quality of life in individuals with anxiety disorders","volume":"157","author":"Mendlowicz","year":"2000","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_bib118","doi-asserted-by":"crossref","unstructured":"Mitte, K., in press. A meta-analysis of cognitive behavioral treatments for generalized anxiety disorder. A comparison with pharmacotherapy. Psychological Bulletin.","DOI":"10.1037\/0033-2909.131.5.785"},{"key":"10.1016\/j.jad.2005.05.003_bib125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S1352465899271081","article-title":"The efficacy and cognitive processes of cognitive behaviour therapy in the treatment of panic disorder with agoraphobia","volume":"27","author":"Oei","year":"1999","journal-title":"Behavioural and Cognitive Psychotherapy"},{"key":"10.1016\/j.jad.2005.05.003_bib137","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1037\/0022-006X.64.6.1316","article-title":"How interchangeable are different estimators of effect size?","volume":"64","author":"Ray","year":"1996","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1016\/j.jad.2005.05.003_bib140","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000050323","article-title":"Effektivit\u00e4t psychologischer Therapien von Panik und Agoraphobie: Meta-Analysen auf St\u00f6rungsebene","volume":"11","author":"Ruhmland","year":"2001","journal-title":"Verhaltenstherapie"},{"key":"10.1016\/j.jad.2005.05.003_bib184","series-title":"The handbook of research synthesis","first-page":"261","article-title":"Combining estimates of effect size","author":"Shadish","year":"1994"},{"key":"10.1016\/j.jad.2005.05.003_bib152","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0887-6185(90)90012-X","article-title":"Economic and life consequences experienced by a group of individuals with panic disorder","volume":"4","author":"Siegel","year":"1990","journal-title":"Journal of Anxiety Disorders"},{"key":"10.1016\/j.jad.2005.05.003_bib164","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/00005053-199708000-00006","article-title":"A meta-analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive behavioral, and combination treatments","volume":"185","author":"Van Balkom","year":"1997","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.jad.2005.05.003_bib172","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1037\/0022-006X.69.6.875","article-title":"A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapies","volume":"69","author":"Westen","year":"2001","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1016\/j.jad.2005.05.003_bib173","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0272-7358(97)00084-6","article-title":"Cognitive behavioural therapy and pharmacotherapy: complementary or contradictory approaches to the treatment of anxiety?","volume":"18","author":"Westra","year":"1998","journal-title":"Clinical Psychology Review"},{"key":"10.1016\/j.jad.2005.05.003_bib174","series-title":"Anxiety and Its Disorders: The Nature and Treatment of Anxiety and Panic","first-page":"328","article-title":"Panic disorder and agoraphobia","author":"White","year":"2002"},{"key":"10.1016\/j.jad.2005.05.003_bib185","first-page":"151","article-title":"Benzodiazepines: use, abuse, and consequences","volume":"44","author":"Woods","year":"1992","journal-title":"Pharmacological Review"},{"key":"10.1016\/j.jad.2005.05.003_bib179","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1176\/ajp.155.5.596","article-title":"Is the course of panic disorder the same in women and men?","volume":"155","author":"Yonkers","year":"1998","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0005-7967(01)00014-6","article-title":"Cognitive therapy versus interoceptive exposure as treatment of panic disorder without agoraphobia","volume":"40","author":"Arntz","year":"2002","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0005-7967(95)00061-5","article-title":"Psychological treatments of panic disorder without agoraphobia: cognitive therapy versus applied relaxation","volume":"34","author":"Arntz","year":"1996","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(01)00265-7","article-title":"Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients","volume":"103","author":"Asnis","year":"2001","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.jad.2005.05.003_fr4","first-page":"402","article-title":"Comparison of fluvoxamine alone, fluvoxamine and cognitive psychotherapy alone in the treatment of panic disorder in Kelantan. Implications for management by family doctors","volume":"55","author":"Azhar","year":"2000","journal-title":"Medical Journal of Malaysia"},{"key":"10.1016\/j.jad.2005.05.003_fr5","first-page":"135","article-title":"A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia","volume":"32","author":"Bakish","year":"1996","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1016\/j.jad.2005.05.003_fr8","doi-asserted-by":"crossref","first-page":"831","DOI":"10.4088\/JCP.v60n1205","article-title":"Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder","volume":"60","author":"Bakker","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/archpsyc.1988.01800290027004","article-title":"Alprazolam in panic disorder and agoraphobia: results from a multicenter trial","volume":"45","author":"Ballenger","year":"1988","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1176\/ajp.155.1.36","article-title":"Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder","volume":"155","author":"Ballenger","year":"1998","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0005-7894(84)80048-9","article-title":"Panic and generalized anxiety disorder: nature and treatment","volume":"15","author":"Barlow","year":"1984","journal-title":"Behavior Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0005-7894(89)80073-5","article-title":"Behavioral treatment of panic disorder","volume":"20","author":"Barlow","year":"1989","journal-title":"Behavior Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr17","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1001\/jama.283.19.2529","article-title":"Cognitive-behavioral therapy, imipramine, or their combination for panic disorder. A randomized controlled trial","volume":"283","author":"Barlow","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2005.05.003_fr19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00004714-199404000-00005","article-title":"Clonazepam in the treatment of panic disorder: a double-blind, placebo-controlled trial investigating the correlation between clonazepam concentrations in plasma and clinical response","volume":"14","author":"Beauclair","year":"1994","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2005.05.003_fr20","series-title":"Panic: Psychological Perspectives","article-title":"Cognitive approaches to panic disorder: theory and therapy","author":"Beck","year":"1988"},{"key":"10.1016\/j.jad.2005.05.003_fr22","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1176\/ajp.149.6.778","article-title":"A crossover study of focused cognitive therapy for panic disorder","volume":"149","author":"Beck","year":"1992","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr23","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1037\/0022-006X.62.4.818","article-title":"Comparison of cognitive therapy and relaxation training for panic disorder","volume":"62","author":"Beck","year":"1994","journal-title":"Journal of Consulting and Clinical Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archpsyc.1993.01820130046008","article-title":"A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder","volume":"50","author":"Black","year":"1993","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF01205172","article-title":"Mechanisms of change in the treatment of panic","volume":"15","author":"Borden","year":"1991","journal-title":"Cognitive Therapy and Research"},{"key":"10.1016\/j.jad.2005.05.003_fr29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0005-7967(95)00077-1","article-title":"Exposure versus cognitive restructuring in the treatment of panic disorder with agoraphobia","volume":"34","author":"Bouchard","year":"1996","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr32","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1176\/ajp.155.5.603","article-title":"Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder","volume":"155","author":"Broocks","year":"1998","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.2044-8260.1997.tb01248.x","article-title":"Treatment choice for agoraphobic women: exposure or cognitive-behaviour therapy?","volume":"36","author":"Burke","year":"1997","journal-title":"British Journal of Clinical Psychology"},{"key":"10.1016\/j.jad.2005.05.003_fr35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-0447.1999.tb05384.x","article-title":"Comparative effects of low and high doses of clomipramine and placebo in panic disorder: a double-blind controlled study","volume":"99","author":"Caillard","year":"1999","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.jad.2005.05.003_fr36","first-page":"202","article-title":"Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy","volume":"56","author":"Carter","year":"1995","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0005-7967(79)90039-1","article-title":"Flooding with brevital in the treatment of agoraphobia: countereffective?","volume":"17","author":"Chambless","year":"1979","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr41","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1192\/bjp.164.6.759","article-title":"A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder","volume":"164","author":"Clark","year":"1994","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr42","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1037\/0022-006X.67.4.583","article-title":"Brief cognitive therapy for panic disorder: a randomized controlled trial","volume":"67","author":"Clark","year":"1999","journal-title":"Journal of Consulting and Clinical Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr45","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF01089774","article-title":"A comparison of guided imaginal coping and imaginal exposure in the treatment of panic disorder","volume":"11","author":"Clum","year":"1993","journal-title":"Journal of Rational-Emotive and Cognitive-Behaviour Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr47","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1192\/bjp.167.5.635","article-title":"A controlled study of cognitive behaviour therapy with buspirone or placebo in panic disorder with agoraphobia","volume":"167","author":"Cottraux","year":"1995","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0005-7916(95)00003-I","article-title":"Brief cognitive-behavioral versus non-directive therapy for panic disorder","volume":"26","author":"Craske","year":"1995","journal-title":"Journal of Behavior Therapy and Experimental Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/10401239209150457","article-title":"Long-term outcome of panic states during double-blind treatment and after withdrawal of alprazolam and placebo","volume":"4","author":"Dager","year":"1992","journal-title":"Annals of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr52","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00004714-199408000-00005","article-title":"Adinazolam sustained-release treatment of panic disorder: a double-blind study","volume":"14","author":"Davidson","year":"1994","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2005.05.003_fr53","first-page":"683","article-title":"Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone","volume":"152","author":"DeBeurs","year":"1994","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr54","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF02245749","article-title":"Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin","volume":"102","author":"Den Boer","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2005.05.003_fr55","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0005-7967(89)90148-4","article-title":"Breathing retraining, exposure and a combination of both, in the treatment of panic disorder with agoraphobia","volume":"27","author":"De Ruiter","year":"1989","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr56","first-page":"458","article-title":"Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study","volume":"47","author":"Dunner","year":"1986","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr58","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1017\/S1352465800010481","article-title":"Interactions between self-exposure and alprazolam in the treatment of agoraphobia without current panic: an exploratory study","volume":"21","author":"Echebur\u00faa","year":"1993","journal-title":"Behavioural and Cognitive Psychotherapy"},{"key":"10.1016\/j.jad.2005.05.003_fr59","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0005-7967(74)90119-3","article-title":"Self-observation versus flooding in the treatment of agoraphobia","volume":"12","author":"Emmelkamp","year":"1974","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr60","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF01185728","article-title":"Cognition and exposure in vivo in the treatment of agoraphobia: short-term and delayed effects","volume":"6","author":"Emmelkamp","year":"1982","journal-title":"Cognitive Therapy and Research"},{"key":"10.1016\/j.jad.2005.05.003_fr61","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0005-7967(78)90087-6","article-title":"Cognitive modification versus prolonged exposure in vivo: a comparison with agoraphobic as subjects","volume":"16","author":"Emmelkamp","year":"1978","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr62","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/01454455860101003","article-title":"The treatment of agoraphobia. A comparison of self-instructional training, rational emotive therapy, and exposure in vivo","volume":"10","author":"Emmelkamp","year":"1986","journal-title":"Behavior Modification"},{"key":"10.1016\/j.jad.2005.05.003_fr63","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3109\/00048679109062635","article-title":"Long term follow-up of agoraphobics treated by brief intensive group cognitive behavioural therapy","volume":"25","author":"Evans","year":"1991","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr64","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0447.1986.tb02666.x","article-title":"Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks","volume":"73","author":"Evans","year":"1986","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.jad.2005.05.003_fr65","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0165-0327(92)90094-M","article-title":"The Galway study of panic disorder: I. Clomipramine and lofepramine in DSM III-R panic disorder: a placebo controlled trial","volume":"25","author":"Fahy","year":"1992","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2005.05.003_fr66","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0005-7894(99)80004-5","article-title":"The limits of bibliotherapy: a study of the differential effectiveness of self-administered interventions in individuals with panic attacks","volume":"30","author":"Febbraro","year":"1999","journal-title":"Behavior Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr69","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/026988119300700402","article-title":"Clomipramine, a better reference drug for panic\/agoraphobia","volume":"7","author":"Gentil","year":"1993","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.jad.2005.05.003_fr70","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00004714-200104000-00003","article-title":"Absence of neuropsychologic deficits in patients receiving long-term treatment with alprazolam-XR for panic disorder","volume":"21","author":"Gladsjo","year":"2001","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2005.05.003_fr74","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0005-7894(05)80099-1","article-title":"Self-help plus minimal therapist contact in the treatment of panic disorder: a replication and extension","volume":"26","author":"Gould","year":"1995","journal-title":"Behavior Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr75","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0005-7894(05)80266-7","article-title":"The use of bibliotherapy in the treatment of panic: a preliminary investigation","volume":"24","author":"Gould","year":"1993","journal-title":"Behavior Therapy"},{"issue":"9","key":"10.1016\/j.jad.2005.05.003_fr77","first-page":"4120-B","article-title":"Breathing retraining in panic disorder: physiological mechanisms or perceived controllability","volume":"55","author":"Griegel","year":"1995","journal-title":"Dissertational Abstracts International"},{"key":"10.1016\/j.jad.2005.05.003_fr80","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1017\/S1352465898000137","article-title":"Cognitive restructuring and interoceptive exposure in the treatment of panic disorder: a crossover study","volume":"26","author":"Hecker","year":"1998","journal-title":"Behavioural and Cognitive Psychotherapy"},{"key":"10.1016\/j.jad.2005.05.003_fr83","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00004714-199310000-00004","article-title":"Effect of fluvoxamine on panic disorder","volume":"13","author":"Hoehn-Saric","year":"1993","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2005.05.003_fr84","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0005-7967(94)00056-P","article-title":"A comparison of cognitive and guided mastery therapy of agoraphobia","volume":"33","author":"Hoffart","year":"1995","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr86","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/archpsyc.1988.01800290073009","article-title":"Clomipramine treatment of agoraphobic women","volume":"45","author":"Johnston","year":"1988","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr88","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0165-0327(93)90074-T","article-title":"Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo","volume":"28","author":"Keller","year":"1993","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2005.05.003_fr92","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1017\/S1352465801001138","article-title":"A brief interned-based treatment for panic disorder","volume":"29","author":"Klein","year":"2001","journal-title":"Behavioural and Cognitive Psychotherapy"},{"key":"10.1016\/j.jad.2005.05.003_fr93","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/archpsyc.1988.01800290021003","article-title":"Overview of the cross-national collaborative panic study","volume":"45","author":"Klerman","year":"1988","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr95","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1037\/0022-006X.58.1.77","article-title":"A comparison of alprazolam and behavior therapy in treatment of panic disorder","volume":"58","author":"Klosko","year":"1990","journal-title":"Journal of Consulting and Clinical Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr96","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0447.1997.tb00388.x","article-title":"A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder","volume":"95","author":"Lecrubier","year":"1997","journal-title":"Acta Psyciatrica Scandinavica"},{"key":"10.1016\/j.jad.2005.05.003_fr97","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1037\/0022-006X.62.4.865","article-title":"A comparison of bibliotherapy and group therapy in the treatment of panic disorder","volume":"62","author":"Lidren","year":"1994","journal-title":"Journal of Consulting and Clinical Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr98","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00421708","article-title":"The management of severe agoraphobia: a comparison of iproniazid and systematic desensitization","volume":"32","author":"Lipsedge","year":"1973","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.jad.2005.05.003_fr100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1192\/bjp.174.3.205","article-title":"Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia","volume":"174","author":"Loerch","year":"1999","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr101","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1192\/bjp.173.1.54","article-title":"Sertraline in the treatment of panic disorder","volume":"173","author":"Londborg","year":"1998","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr102","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00004714-199204000-00004","article-title":"A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder","volume":"12","author":"Lydiard","year":"1992","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2005.05.003_fr103","first-page":"183","article-title":"Preliminary report: placebo-controlled, double-blind study of the clinical and metabolic effects of desipramine in panic disorder","volume":"29","author":"Lydiard","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2005.05.003_fr104","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0005-7967(87)90010-6","article-title":"Cognitive behavioral treatment of agoraphobia","volume":"25","author":"Marchione","year":"1987","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr105","article-title":"Outcome and active ingredients of cognitive-behavioural treatments for panic disorder","author":"Margraf","year":"1991"},{"key":"10.1016\/j.jad.2005.05.003_fr109","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/archpsyc.1983.01790020047004","article-title":"Imipramine and brief therapist-aided exposure in agoraphobics having selfexposure homework","volume":"40","author":"Marks","year":"1983","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr110","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1192\/bjp.162.6.776","article-title":"Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto","volume":"162","author":"Marks","year":"1993","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr112","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0005-7894(83)80074-4","article-title":"Self-directed in vivo exposure pracrice in behavioral and pharmacological treatments of agoraphobia","volume":"14","author":"Mavissakalian","year":"1983","journal-title":"Behavior Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr113","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1176\/ajp.152.5.673","article-title":"Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level\u2013response relationships","volume":"152","author":"Mavissakalian","year":"1995","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0005-7894(88)80035-2","article-title":"Cognitive, behavioral, and psychophysiological treatments of agoraphobia: a comparative outcome investigation","volume":"19","author":"Michelson","year":"1988","journal-title":"Behavior Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr116","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0887-6185(96)00001-1","article-title":"A comparative outcome and follow-up investigation of panic disorder with agoraphobia: the relative and combined efficacy of cognitive therapy, relaxation training, and therapist-assisted exposure","volume":"10","author":"Michelson","year":"1996","journal-title":"Journal of Anxiety Disorders"},{"key":"10.1016\/j.jad.2005.05.003_fr117","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1176\/ajp.155.11.1570","article-title":"Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo","volume":"155","author":"Michelson","year":"1998","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr119","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00004714-199208000-00007","article-title":"Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial","volume":"12","author":"Modigh","year":"1992","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2005.05.003_fr120","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4088\/JCP.v60n0907","article-title":"Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages","volume":"60","author":"Moroz","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr121","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00004714-198902000-00005","article-title":"Alprazoalm, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks","volume":"9","author":"Munjack","year":"1989","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2005.05.003_fr122","first-page":"349","article-title":"Diazepam versus alprazolam for the treatment of panic disorder","volume":"57","author":"Noyes","year":"1996","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr123","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1192\/bjp.167.3.374","article-title":"Paroxetine in the treatment of panic disorder. A randomized, double-blind, placebo-controlled study","volume":"167","author":"Oehrberg","year":"1995","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr124","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0005-7967(97)00038-7","article-title":"Does concurrent drug intake affect the long-term outcome of group cognitive behaviour therapy in panic disorder with or without agoraphobia?","volume":"35","author":"Oei","year":"1997","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr126","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0005-7967(94)E0026-F","article-title":"Applied relaxation vs cognitive behavior therapy in the treatment of panic disorder","volume":"33","author":"\u00d6st","year":"1995","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr127","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0005-7967(93)90095-C","article-title":"Applied relaxation, exposure in vivo and cognitive methods in the treatment of panic disorder with agoraphobia","volume":"31","author":"\u00d6st","year":"1993","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr128","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1176\/appi.ajp.158.12.1989","article-title":"An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder","volume":"158","author":"Otto","year":"2001","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr129","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/00004714-200008000-00011","article-title":"Placebo-controlled study of gabapentin treatment of panic disorder","volume":"20","author":"Pande","year":"2000","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2005.05.003_fr130","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00004714-199410000-00005","article-title":"A double-blind, placebo-controlled, multicenter study with alprazolam and extended-release alprazolam in the treatment of panic disorder","volume":"14","author":"Pecknold","year":"1994","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2005.05.003_fr131","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/09515079608256363","article-title":"Panic disorder: a cognitive-behavioural approach to treatment","volume":"9","author":"Petterson","year":"1996","journal-title":"Counselling Psychology Quarterly"},{"key":"10.1016\/j.jad.2005.05.003_fr132","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000284627","article-title":"Serotonergic anxiolytics in the treatment of panic disorder: a controlled study with buspirone","volume":"22","author":"Pohl","year":"1989","journal-title":"Psychopathology"},{"key":"10.1016\/j.jad.2005.05.003_fr133","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1176\/ajp.155.9.1189","article-title":"Sertraline in the treatment of panic disorder: a double-blind multicenter trial","volume":"155","author":"Pohl","year":"1998","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr134","first-page":"667","article-title":"Venlafaxine for panic disorder: results from a double-blind, placebo-controlled trial","volume":"32","author":"Pollack","year":"1996","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1016\/j.jad.2005.05.003_fr135","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/archpsyc.55.11.1010","article-title":"Sertraline in the treatment of panic disorder","volume":"55","author":"Pollack","year":"1998","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr138","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00005053-198704000-00006","article-title":"Personality of panic disorder alcohol abusers","volume":"175","author":"Reich","year":"1987","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.jad.2005.05.003_fr139","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00004714-199710000-00008","article-title":"Clonazepam in the treatment of panic disorder with or without agoraphobia: a dose\u2013response study of efficacy, safety, and discontinuance","volume":"17","author":"Rosenbaum","year":"1997","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2005.05.003_fr141","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/026988110101500312","article-title":"Crossover trial of pagoclone and placebo in patients with DSM-VI panic disorder","volume":"15","author":"Sandford","year":"2001","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.jad.2005.05.003_fr142","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-2007-979311","article-title":"Fluvoxamine or placebo in the treatment of panic disorder and relationship to blood concentrations of fluvoxamine","volume":"31","author":"Sandmann","year":"1998","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr143","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/milmed\/162.2.123","article-title":"Efficacy of a brief psychosocial treatment for panic disorder in an active duty sample: implications for military readiness","volume":"162","author":"Schmidt","year":"1997","journal-title":"Military Medicine"},{"key":"10.1016\/j.jad.2005.05.003_fr144","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1037\/0021-843X.106.4.630","article-title":"Extinction of panicogenic effects of a 35% CO2 challenge in patients with panic disorder","volume":"106","author":"Schmidt","year":"1997","journal-title":"Journal of Abnormal Psychology"},{"key":"10.1016\/j.jad.2005.05.003_fr145","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1037\/0022-006X.68.3.417","article-title":"Dismantling cognitive-behavioral treatment for panic disorder: questioning the utility of breathing retraining","volume":"68","author":"Schmidt","year":"2000","journal-title":"Journal of Consulting and Clinical Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr146","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1176\/ajp.150.8.1210","article-title":"Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder","volume":"150","author":"Schweizer","year":"1993","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr147","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archpsyc.1993.01820130053009","article-title":"Maintenance drug treatment of panic disorder","volume":"50","author":"Schweizer","year":"1993","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr148","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0887-6185(96)00008-4","article-title":"Fluvoxamine, placebo, and cognitive behaviour therapy used alone and in combination in the treatment of panic disorder and agoraphobia","volume":"10","author":"Sharp","year":"1996","journal-title":"Journal of Anxiety Disorders"},{"key":"10.1016\/j.jad.2005.05.003_fr149","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/archpsyc.1994.03950050055006","article-title":"Cognitive behavioral treatment compared with nonprescriptive treatment of panic disorder","volume":"51","author":"Shear","year":"1994","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00004714-199002000-00002","article-title":"Is buspirone effective for panic disorder?","volume":"10","author":"Sheehan","year":"1990","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2005.05.003_fr151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1993.tb03405.x","article-title":"The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: a double-blind placebo-controlled study","volume":"88","author":"Sheehan","year":"1993","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.jad.2005.05.003_fr153","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0005-7967(81)90055-3","article-title":"Augmentation of in vivo exposure treatment for agoraphobia by the formation of neighbourhood self-help groups","volume":"19","author":"Sinnott","year":"1981","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr155","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0165-1781(00)00154-2","article-title":"Do selective serotonin re-uptake inhibitors enhance the efficacy of very brief cognitive-behavioral therapy for panic disorder? A pilot study","volume":"94","author":"Stein","year":"2000","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.jad.2005.05.003_fr156","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0005-7967(94)00061-N","article-title":"Efficacy of telephone-administered behavioral therapy for panic disorder with agoraphobia","volume":"33","author":"Swinson","year":"1995","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr157","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/00004714-199004000-00006","article-title":"Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients panic disorder: results of a double-blind, placebo-controlled trial","volume":"10","author":"Taylor","year":"1990","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2005.05.003_fr158","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0005-7967(85)90011-7","article-title":"Combined pharmacological and behavioral treatment for agoraphobia","volume":"23","author":"Telch","year":"1985","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr159","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0005-7967(93)90026-Q","article-title":"Group cognitive-behavioral treatment of panic disorder","volume":"31","author":"Telch","year":"1993","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr160","first-page":"69","article-title":"Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder","volume":"52","author":"Tesar","year":"1991","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr161","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000289151","article-title":"The benefit of an insight-oriented and experiential approach on panic and agoraphobia symptoms","volume":"66","author":"Teusch","year":"1997","journal-title":"Psychotherapy and Psychosomatics"},{"key":"10.1016\/j.jad.2005.05.003_fr162","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0165-0327(89)90009-8","article-title":"Response of panic disorder to fixed doses of alprazolam or imipramine","volume":"17","author":"Uhlenhuth","year":"1989","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2005.05.003_fr163","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1590\/S0004-282X2000000600008","article-title":"Double-blind clonazepam vs placebo in panic disorder treatment","volume":"58","author":"Valenca","year":"2000","journal-title":"Arquives Neuropsiquiatrica"},{"key":"10.1016\/j.jad.2005.05.003_fr165","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0005-7967(94)90008-6","article-title":"Exposure reduced agoraphobia but not panic, and cognitive therapy reduced panic but not agoraphobia","volume":"32","author":"Van den Hout","year":"1994","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.jad.2005.05.003_bib166","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s002130050201","article-title":"Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks","volume":"129","author":"van Megen","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2005.05.003_fr167","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF02244898","article-title":"MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine","volume":"112","author":"van Vliet","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2005.05.003_fr168","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF02805991","article-title":"Effects of the 5-HT1A receptor agonist flesinoxan in panic disorder","volume":"127","author":"van Vliet","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2005.05.003_fr169","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4088\/JCP.v63n0107","article-title":"Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder","volume":"63","author":"Versiani","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr170","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1192\/bjp.170.6.549","article-title":"The effect of citalopram in panic disorder","volume":"170","author":"Wade","year":"1997","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr171","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0005-7967(94)90113-9","article-title":"Effects of concurrent diazepam treatment on the outcome of exposure therapy in agoraphobia","volume":"32","author":"Wardle","year":"1994","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr175","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0005-7967(95)00063-1","article-title":"Cognitive and performance-based treatments for panic attacks in people with varying degrees of agoraphobic disability","volume":"34","author":"Williams","year":"1996","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr176","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0005-7894(83)80120-8","article-title":"Cognitive treatment in the natural environment for agoraphobics","volume":"14","author":"Williams","year":"1983","journal-title":"Behavior Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr177","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2190\/X6N2-8HYG-7LLJ-X6U2","article-title":"Clonazepam treatment of panic disorder in patients with recurrent chest pain and normal coronary arteries","volume":"29","author":"Wulsin","year":"1999","journal-title":"International Journal of Psychiatry in Medicine"},{"key":"10.1016\/j.jad.2005.05.003_fr178","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1067\/mem.2002.121484","article-title":"A randomized, controlled trial of panic disorder treatment initiation in an emergency department chest pain center","volume":"39","author":"Wulsin","year":"2002","journal-title":"Annals of Emergency Medicine"},{"key":"10.1016\/j.jad.2005.05.003_fr180","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0005-7894(05)80322-3","article-title":"Performance-related anxiety in agoraphobia: treatment procedures and cognitive mechanisms of change","volume":"24","author":"Zane","year":"1993","journal-title":"Behavior Therapy"},{"key":"10.1016\/j.jad.2005.05.003_fr181","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archpsyc.1980.01780140065007","article-title":"Treatment of agoraphobia with group exposure in vivo and imipramine","volume":"37","author":"Zitrin","year":"1980","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2005.05.003_fr182","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/archpsyc.1983.01790020019002","article-title":"Treatment of phobias: I. Comparison of imipramine hydrochloride and placebo","volume":"40","author":"Zitrin","year":"1983","journal-title":"Archives of General Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032705001278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032705001278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T07:08:42Z","timestamp":1586329722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032705001278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":178,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0165032705001278"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2005.05.003","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}